SCHEMBL12835110

SCHEMBL12835110

Cn1c2ccccc2c2cc3c(-c4ccccc4)c4cc5c(cc4c(-c4ccccc4)c3cc21)c1ccccc1n5C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.57
▸ KDM4E B2RXH2 4/20 0.50
▸ KMT2A Q03164 3/20 0.49
▸ LMNA P02545 3/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ HPGD P15428 4/20 0.49
▸ HSD17B10 Q99714 4/20 0.49
▸ ALDH1A1 P00352 4/20 0.49
▸ MAPT P10636 3/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ PABPC1 P11940 1/20 0.47
▸ KIF11 P52732 1/20 0.47
▸ RXRA P19793 1/20 0.46
▸ RXRB P28702 1/20 0.46
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12835111 0.98 GPR3 (0.55) GPR3KDM4EKMT2ALMNASMN1; SMN2
SCHEMBL3423941 0.84 GPR3 (0.80) GPR3KDM4EKMT2ALMNAHPGD
SCHEMBL15196326 0.83 GPR3 (0.53) GPR3KDM4EKMT2ALMNASMN1; SMN2
SCHEMBL15196349 0.83 GPR3 (0.53) GPR3KDM4EKMT2ALMNASMN1; SMN2
SCHEMBL18416289 0.83 GPR3 (0.70) GPR3KDM4EKMT2ALMNAHPGD
SCHEMBL9889048 0.82 GPR3 (0.76) GPR3KDM4EKMT2ALMNAHPGD
SCHEMBL12873195 0.82 KDM4E (0.50) GPR3KDM4EKMT2ALMNAHPGD
SCHEMBL9890924 0.81 GPR3 (0.52) GPR3KDM4EKMT2ALMNASMN1; SMN2
SCHEMBL12703017 0.81 KDM4E (0.49) GPR3KDM4EKMT2ALMNAHPGD
SCHEMBL25987288 0.80 GPR3 (0.59) GPR3KDM4EKMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2662356-B1 Condensed-cyclic compound and organic light emitting diode having organic layer including the same SAMSUNG DISPLAY CO LTD (KR) 2016-10-12 — — EP disclosed
EP-2292604-B1 Condensed-cyclic compound and organic light emitting diode having organic layer including the same SAMSUNG DISPLAY CO LTD (KR) 2016-01-27 — — EP disclosed
US-9045419-B2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-06-02 — — US disclosed
US-9045419-B2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-06-02 — — US disclosed
EP-2662356-A1 Condensed-cyclic compound and organic light emitting diode having organic layer including the same Samsung Display Co., Ltd. (KR) 2013-11-13 — — EP disclosed
EP-2292604-A2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same Samsung Mobile Display Co., Ltd. (KR) 2011-03-09 — — EP disclosed
US-20110031484-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-02-10 — — US disclosed
US-20110031484-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110031484-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME CRY1, CCNL2, CCNT1 GPR3 3622/4885KDM4E 3376/4885KMT2A 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback